Stocks and Investing Stocks and Investing
Thu, April 11, 2024

Derek Archila Initiated (ANAB) at Buy and Held Target at $56 on, Apr 11th, 2024


Published on 2024-10-28 10:17:47 - WOPRAI, Derek Archila
  Print publication without navigation


Derek Archila of Wells Fargo, Initiated "AnaptysBio, Inc." (ANAB) at Buy and Held Target at $56 on, Apr 11th, 2024.

Derek has made no other calls on ANAB in the last 4 months.



There are 5 other peers that have a rating on ANAB. Out of the 5 peers that are also analyzing ANAB, 1 agrees with Derek's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Anupam Rama of "JP Morgan" Maintained at Hold with Decreased Target to $28 on, Monday, April 1st, 2024


These are the ratings of the 4 analyists that currently disagree with Derek


  • David Nierengarten of "Wedbush" Upgraded from Hold to Buy and Increased Target to $34 on, Tuesday, March 12th, 2024
  • Julian Harrison of "BTIG" Initiated at Strong Buy and Held Target at $55 on, Monday, February 26th, 2024
  • Alex Schwartz of "Stifel" Initiated at Strong Buy and Held Target at $50 on, Wednesday, February 21st, 2024
  • Yasmeen Rahimi of "Piper Sandler" Initiated at Buy and Held Target at $80 on, Friday, February 16th, 2024
Contributing Sources